Executive Director, Quality
Gilead Sciences
I am a forward-thinking Executive Director in Quality specializing in Biopharmaceutical Company Quality Systems in the AI Era. With a remarkable history of leading transformative initiatives, I am dedicated to fostering a culture of excellence specifically tailored to the dynamic landscape of biopharmaceuticals and artificial intelligence.
My expertise lies in seamlessly integrating cutting-edge AI technologies into quality systems, ensuring they align with the highest standards and overarching business objectives. Having served as a seasoned quality systems expert in a top-tier biopharmaceutical company, I've driven sustainable process improvements and adeptly navigated the complexities of AI integration in challenging audit scenarios.
Functioning as a natural servant leader, I am recognized for developing, coaching, and mentoring staff across all organizational levels. My focus is on enhancing their technical proficiency in AI-driven quality systems and fostering interpersonal skills, guiding them towards impactful outcomes that significantly contribute to the success of the business in the era of AI advancements.
As a conference speaker, I am eager to share insights into navigating the convergence of biopharmaceutical quality systems and AI technologies. Join me in exploring how my experiences and perspectives can shape the future of quality management in the exciting and rapidly evolving AI era within the biopharmaceutical industry.
Drug Development in the EU: Regulatory Standards, Supports, and New Approaches
Monday, September 16, 2024
8:30 AM – 4:00 PM PDT
Considerations for Global Harmonization and Accelerated Drug Development
Thursday, September 19, 2024
4:30 PM – 5:30 PM PDT